New TB Drug Gets Mixed Reaction

The University of Cape Town's (UCT) head of Pulmonology division, Professor Keertan Dheda, says he is less optimistic about the cocktail of new drug resistance tuberculosis (TB).

The PaMZ three-drug combo from the Global Alliance for TB Drug Development is said to cure the disease more quickly than current regimens.

The PaMZ regimen shows promise to be effective in all (100 percent) of drug-sensitive patients and about 30 percent of patients with MDR-TB

To read the article titled, "New TB treatment drug gets mixed reaction," click here.

Source: 
SABC News

NGO Services

NGO Services

NGO Events

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
 
29
 
30